NSE filing, NSE: MEDIORG. Summary written from the filing by ALFA Finder's alert engine.
Medicamen Organics Ltd: key numbers
- Share price
- ₹25.25
- Market cap
- ₹37.57 Cr
- Revenue (annual)
- ₹22.63 Cr
- Net profit (annual)
- ₹-4.02 Cr
- P/E (TTM)
- -9.3×Sector 46.1×
- Promoter holding
- 54.89%
- FII holding
- 0.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medicamen Organics Ltd
All →Medicamen Organics Annual General Meeting
Medicamen Organics held its 31st AGM on September 25, 2026. Shareholders approved audited financial statements, director reappointment, secretarial auditor appointment, and related party transactions.
Medicamen Organics Other Announcement
Medicamen Organics Limited informed shareholders about the web-link to access the Notice of the 31st AGM and Annual Report for FY 2025-26, as per regulatory compliance.
Medicamen Organics Annual General Meeting
Medicamen Organics Ltd has scheduled its 31st Annual General Meeting for September 25, 2026. The board also approved the re-appointment of its Secretarial Auditors.
Medicamen Organics Management Change
Mr. Brijesh Kumar Chaubey has resigned as Executive Director of Medicamen Organics Limited. The resignation is effective July 20, 2026, due to family medical issues.
Medicamen Organics Fund Raise of ₹12.29 Cr
Medicamen Organics Limited received Rs. 12.29 Crore in consideration for a preferential allotment of equity shares and warrants. The auditor certified compliance with SEBI ICDR Regulations.
- Value
- ₹12.29 Cr
Medicamen Organics Fund Raise of ₹13.65 Cr
Medicamen Organics allotted equity shares and warrants worth ₹13.65 Crore on a preferential basis. This capital infusion strengthens the company's equity base and supports future growth.
- Value
- ₹13.65 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.